Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of gestational diabetes and preeclampsia in pregnant women with polycystic ovary syndrome
IRCT20120215009014N252Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metformin in gestational diabetes mellitus (GDM) and preeclampsia (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Incidence of gestational diabetes and Incidence of preeclampsia. Started Dec 2018; status: completed.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)preeclampsia
Beyond the preview
Go deeper on IRCT20120215009014N252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N252.